US Patent 11020435 Functionalized erythroid cells
Patent 11020435 was granted and assigned to Rubius Therapeutics on June, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+197 characters)
Article
Patent abstract
Described herein are novel preparations of functionalized erythroid cells and related compositions, reagents, and methods for use in human pharmaceutical and veterinary applications.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Billy Law0
Carolyn Sayre0
Jordi Mata-Fink0
Kristian Eric Teichert0
Lenka Hoffman0
Shamael Rabia Dastagir0
Sivan Elloul0
Tiffany F. Chen0
Tom Wickham0
Xuqing Zhang0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Golden AI
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+16 properties)
US Patent 11020435 Functionalized erythroid cells
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11020435
Date of patent
June 1, 2021
Patent application number
15932341
Date Filed
February 16, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 11020435 Functionalized erythroid cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
